Erdafitinib in Urothelial Carcinoma. Reply

N Engl J Med. 2019 Oct 17;381(16):1594-1595. doi: 10.1056/NEJMc1911187.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carcinoma, Transitional Cell*
  • Humans
  • Protein Kinase Inhibitors
  • Urologic Neoplasms*

Substances

  • Protein Kinase Inhibitors